PortalPublikationenS2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische De...

S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion

Standard

S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion. / Werfel, Thomas; Heratizadeh, Annice; Aberer, Werner; Ahrens, Frank; Augustin, Matthias; Biedermann, Tilo; Diepgen, Thomas; Fölster-Holst, Regina; Gieler, Uwe; Kahle, Julia; Kapp, Alexander; Nast, Alexander; Nemat, Katja; Ott, Hagen; Przybilla, Bernhard; Roecken, Martin; Schlaeger, Martin; Schmid-Grendelmeier, Peter; Schmitt, Jochen; Schwennesen, Thomas; Staab, Doris; Worm, Margitta.

in: J DTSCH DERMATOL GES, Jahrgang 14, Nr. 1, 01.2016, S. 92-105.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Werfel, T, Heratizadeh, A, Aberer, W, Ahrens, F, Augustin, M, Biedermann, T, Diepgen, T, Fölster-Holst, R, Gieler, U, Kahle, J, Kapp, A, Nast, A, Nemat, K, Ott, H, Przybilla, B, Roecken, M, Schlaeger, M, Schmid-Grendelmeier, P, Schmitt, J, Schwennesen, T, Staab, D & Worm, M 2016, 'S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion', J DTSCH DERMATOL GES, Jg. 14, Nr. 1, S. 92-105. https://doi.org/10.1111/ddg.12871

APA

Werfel, T., Heratizadeh, A., Aberer, W., Ahrens, F., Augustin, M., Biedermann, T., Diepgen, T., Fölster-Holst, R., Gieler, U., Kahle, J., Kapp, A., Nast, A., Nemat, K., Ott, H., Przybilla, B., Roecken, M., Schlaeger, M., Schmid-Grendelmeier, P., Schmitt, J., ... Worm, M. (2016). S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion. J DTSCH DERMATOL GES, 14(1), 92-105. https://doi.org/10.1111/ddg.12871

Vancouver

Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin M, Biedermann T et al. S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion. J DTSCH DERMATOL GES. 2016 Jan;14(1):92-105. https://doi.org/10.1111/ddg.12871

Bibtex

@article{ead210be1cb14f5e90393ce3b93fc405,
title = "S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion",
abstract = "Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).",
keywords = "Anti-Inflammatory Agents, Dermatitis, Atopic, Dermatology, Evidence-Based Medicine, Germany, Humans, Practice Guidelines as Topic, Skin Tests, Treatment Outcome, Journal Article",
author = "Thomas Werfel and Annice Heratizadeh and Werner Aberer and Frank Ahrens and Matthias Augustin and Tilo Biedermann and Thomas Diepgen and Regina F{\"o}lster-Holst and Uwe Gieler and Julia Kahle and Alexander Kapp and Alexander Nast and Katja Nemat and Hagen Ott and Bernhard Przybilla and Martin Roecken and Martin Schlaeger and Peter Schmid-Grendelmeier and Jochen Schmitt and Thomas Schwennesen and Doris Staab and Margitta Worm",
note = "{\textcopyright} 2015 The Authors | Journal compilation {\textcopyright} Blackwell Verlag GmbH, Berlin.",
year = "2016",
month = jan,
doi = "10.1111/ddg.12871",
language = "Deutsch",
volume = "14",
pages = "92--105",
journal = "J DTSCH DERMATOL GES",
issn = "1610-0379",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion

AU - Werfel, Thomas

AU - Heratizadeh, Annice

AU - Aberer, Werner

AU - Ahrens, Frank

AU - Augustin, Matthias

AU - Biedermann, Tilo

AU - Diepgen, Thomas

AU - Fölster-Holst, Regina

AU - Gieler, Uwe

AU - Kahle, Julia

AU - Kapp, Alexander

AU - Nast, Alexander

AU - Nemat, Katja

AU - Ott, Hagen

AU - Przybilla, Bernhard

AU - Roecken, Martin

AU - Schlaeger, Martin

AU - Schmid-Grendelmeier, Peter

AU - Schmitt, Jochen

AU - Schwennesen, Thomas

AU - Staab, Doris

AU - Worm, Margitta

N1 - © 2015 The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.

PY - 2016/1

Y1 - 2016/1

N2 - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).

AB - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).

KW - Anti-Inflammatory Agents

KW - Dermatitis, Atopic

KW - Dermatology

KW - Evidence-Based Medicine

KW - Germany

KW - Humans

KW - Practice Guidelines as Topic

KW - Skin Tests

KW - Treatment Outcome

KW - Journal Article

U2 - 10.1111/ddg.12871

DO - 10.1111/ddg.12871

M3 - SCORING: Zeitschriftenaufsatz

C2 - 26713654

VL - 14

SP - 92

EP - 105

JO - J DTSCH DERMATOL GES

JF - J DTSCH DERMATOL GES

SN - 1610-0379

IS - 1

ER -